Barrow Hanley Mewhinney & Strauss LLC Amgen Inc Transaction History

Barrow Hanley Mewhinney & Strauss LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $193,257 - $217,872	-1,043 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $32,047 - $35,996	-193 Reduced 15.61%	1,043 $192,000
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $99,794 - $116,622	589 Added 91.04%	1,236 $210,000
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $57,388 - $64,120	340 Added 110.75%	647 $113,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $51,358 - $58,637	307	307 $57,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.